COMPASS THERAPEUTICS, INC. (CMPX) Debt / Equity
- 2021-12-31: Debt/Equity Ratio 0.
- 2021-09-30: Debt/Equity Ratio 0.16.
- 2021-06-30: Debt/Equity Ratio 0.19.
- 2020-12-31: Debt/Equity Ratio 0.23.
Complete source-backed debt/equity ratio history.
- Available history
- 2019-12-31 to 2021-12-31
- Data captured
Historical Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2021-12-31 | 0 |
| 2021-09-30 | 0.16 |
| 2021-06-30 | 0.19 |
| 2020-12-31 | 0.23 |
| 2020-09-30 | 0.24 |
| 2020-06-30 | 0.24 |
| 2019-12-31 | 1.32 |
Annual Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2021-12-31 | 0 |
| 2020-12-31 | 0.23 |
| 2019-12-31 | 1.32 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |